The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

The first clinical experience with the new GORE® septal occluder (GSO)

EuroIntervention 2013;9:959-963 published online ahead of print June 2013. DOI: 10.4244/EIJV9I8A160

1. The Heart Center, Rigshospitalet University Hospital, Copenhagen, Denmark; 2. Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

Aims: A new GORE® septal occluder (GSO) was granted CE mark in Europe in June 2011 for the treatment of

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Impact of changing PSVR thresholds on the patency rates of SFA recanalisation with self-expanding nitinol stents